Ramesh Ramakrishnan

CIK 1845434 · Sr. Vice President, R&D · last filed 2021-08-17

Ramesh Ramakrishnan is a Sr. Vice President, R&D who has filed 2 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for TLIS, was dated Aug 17, 2021. Across all open-market trades the lifetime net is −$194.7K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

2

Lifetime Open-Market Net

-$194.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Talis Biomedical Corp (TLIS) Delisted Sr. Vice President, R&D 57,380 $2.84 $163.0K -$194.7K 2 2021-08-17

Recent Filings

2 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-08-17 Talis Biomedical Corp (TLIS) Delisted Mixed +24,853 -$132.1K EDGAR
2021-02-19 Talis Biomedical Corp (TLIS) Delisted Buy (P) +1,000 $16.0K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.